Oncology

(Image: Getty/luchschen)

Quanterix expands biomarker tech to oncology research

By Melissa Fassbender

Quanterix is expanding its biomarker technology platform to oncology with the launch of a new test bed for up to 10-plex assays, which will enable drug developers to expedite clinical trials, says CEO.

Novartis HQ in Basel, Switzerland (source Novartis)

Novartis to pay $3.9 bn for radiopharma drug & biz

By Flora Southey

Novartis has announced plans to buy radiopharmaceutical firm Advanced Accelerator Applications (AAA), which will add neuroendocrine tumour treatment Lutathera to its portfolio.

Graham Cotton, Senior R&D Group Leader, Almac Discovery; Tracy Robson; and Professor Tim Harrison, VP Discovery Chemistry, Almac Discovery.

Almac Discovery and RCSI enter research collaboration

By Melissa Fassbender

Almac Discovery and the Royal College of Surgeons in Ireland (RCSI) and have announced a research collaboration aimed at understanding how to target therapy-resistant cancer tumors.

(Image: iStock)

CrownBio expands US operations

By Melissa Fassbender

Crown Bioscience has expanded its San Diego facility to create its US Center of Excellence for Oncology in order to support increasing demand for oncology research studies.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All